Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (53 ops.)
Latest filing published 14 Jan 2026 for AKTIS ONCOLOGY, INC.. Read the official filing
Filing timeline
BuySaleAnsbert Gadicke
Insider track record
Disclosed buys
0
Disclosed sells
53
Signal history
Ansbert Gadicke: trading record in brief
Ansbert Gadicke (board member) discloses dealings in 8 companies, chiefly iTeos Therapeutics, Inc., Repare Therapeutics Inc. and Werewolf Therapeutics, Inc. In total, 60 filings cover trades dated from 30 April 2021 to 12 January 2026.
The open-market record consists of 53 sales worth €42.1M, with no purchase. Besides market trades, the filings include 3 share grants.
On 14 January 2026 came the latest disclosure, a transaction in Aktis Oncology, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ansbert Gadicke
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations51 total
1,314,262 sharesCommon StockSEC:0001231919-26-000055:0
▼
Same trade as the filing by MPM BioVentures 2014, L.P., counted once · View ↗
59,277 shares@ US$0.896.5% of flowCommon StockSEC:0001231919-25-000574:0
▼
Same trade as the filing by MPM BioVentures 2014, L.P., counted once · View ↗
60,733 shares@ US$0.987.4% of flowCommon StockSEC:0001231919-25-000564:0
▼
Same trade as the filing by MPM BioVentures 2014, L.P., counted once · View ↗
64,331 shares@ US$0.836.7% of flowCommon StockSEC:0001231919-25-000550:0
▼
Same trade as the filing by MPM BioVentures 2014, L.P., counted once · View ↗
52,627 shares@ US$0.936.1% of flowCommon StockSEC:0001231919-25-000533:0
▼
Same trade as the filing by MPM BioVentures 2014, L.P., counted once · View ↗
90,951 shares@ US$0.9811.0% of flowCommon StockSEC:0001231919-25-000507:0
▼
Same trade as the filing by MPM BioVentures 2014, L.P., counted once · View ↗
68,480 shares@ US$1.119.5% of flowCommon StockSEC:0001231919-25-000459:0
▼
Same trade as the filing by MPM BioVentures 2014, L.P., counted once · View ↗
140,488 shares@ US$1.2221.4% of flowCommon StockSEC:0001231919-25-000439:0
▼
Same trade as the filing by MPM BioVentures 2014, L.P., counted once · View ↗
86,936 shares@ US$1.4315.4% of flowCommon StockSEC:0001231919-25-000404:0
▼
Same trade as the filing by MPM BioVentures 2014, L.P., counted once · View ↗
72,709 shares@ US$1.7215.5% of flowCommon StockSEC:0001231919-25-000373:0
1,031,931 shares@ US$8.0632.9% of flowCommon StockSEC:0001415889-25-013252:0
50,873 shares@ US$0.090.6% of flowCommon StockSEC:0001415889-25-011569:0
304,001 shares0Common StockSEC:0001209191-23-034336:0
178,269 shares@ US$0.74100.0% of flowCommon StockSEC:0001209191-23-031888:0
3,253,796 shares@ US$4.61100.0% of flowCommon StockSEC:0000899243-22-027167:0
158,579 shares@ US$42.0526.1% of flowCommon StockSEC:0001209191-22-002167:0
29,402 shares@ US$34.684.0% of flowCommon StockSEC:0001209191-21-068406:0
9,809 shares@ US$34.621.3% of flowCommon StockSEC:0001209191-21-067705:0
10,952 shares@ US$35.491.5% of flowCommon StockSEC:0001209191-21-067146:0
15,671 shares0Common StockSEC:0001209191-21-066854:0
14,882 shares@ US$27.531.6% of flowCommon StockSEC:0001209191-21-060722:0
14,260 shares@ US$27.091.5% of flowCommon StockSEC:0001209191-21-060489:0
1,922 shares@ US$27.000.2% of flowCommon StockSEC:0001209191-21-060235:0
11,471 shares@ US$27.001.2% of flowCommon StockSEC:0001209191-21-059421:0
32,154 shares@ US$27.003.3% of flowCommon StockSEC:0001209191-21-058208:0
25 of 51 declarations
